Correlation Between SciVision Biotech and Medeon Biodesign

Can any of the company-specific risk be diversified away by investing in both SciVision Biotech and Medeon Biodesign at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining SciVision Biotech and Medeon Biodesign into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between SciVision Biotech and Medeon Biodesign, you can compare the effects of market volatilities on SciVision Biotech and Medeon Biodesign and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in SciVision Biotech with a short position of Medeon Biodesign. Check out your portfolio center. Please also check ongoing floating volatility patterns of SciVision Biotech and Medeon Biodesign.

Diversification Opportunities for SciVision Biotech and Medeon Biodesign

0.28

Correlation Coefficient

SciVision Biotech  Medeon Biodesign

Modest diversification

The 3 months correlation between SciVision and Medeon is 0.28. Overlapping area represents the amount of risk that can be diversified away by holding SciVision Biotech and Medeon Biodesign in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Medeon Biodesign and SciVision Biotech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on SciVision Biotech are associated (or correlated) with Medeon Biodesign. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Medeon Biodesign has no effect on the direction of SciVision Biotech i.e., SciVision Biotech and Medeon Biodesign go up and down completely randomly.

Pair Corralation between SciVision Biotech and Medeon Biodesign

Assuming the 90 days trading horizon SciVision Biotech is expected to generate 1.41 times more return on investment than Medeon Biodesign. However, SciVision Biotech is 1.41 times more volatile than Medeon Biodesign. It trades about 0.04 of its potential returns per unit of risk. Medeon Biodesign is currently generating about -0.15 per unit of risk. If you would invest  10,900  in SciVision Biotech on October 12, 2024 and sell it today you would earn a total of  400.00  from holding SciVision Biotech or generate 3.67% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

SciVision Biotech  vs.  Medeon Biodesign

SciVision Biotech

Risk-Adjusted Performance

2 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in SciVision Biotech are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of fairly stable basic indicators, SciVision Biotech is not utilizing all of its potentials. The latest stock price fuss, may contribute to near-short-term losses for the sophisticated investors.

Medeon Biodesign

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Medeon Biodesign has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of abnormal performance in the last few months, the Stock's basic indicators remain fairly stable which may send shares a bit higher in February 2025. The latest fuss may also be a sign of long-term up-swing for the venture sophisticated investors.

Pair Trading with SciVision Biotech and Medeon Biodesign

The main advantage of trading using opposite SciVision Biotech and Medeon Biodesign positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if SciVision Biotech position performs unexpectedly, Medeon Biodesign can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Medeon Biodesign will offset losses from the drop in Medeon Biodesign's long position.

The idea behind SciVision Biotech and Medeon Biodesign pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.